Skip to Content
Looking to save on your medications?  Find out how 

Pill Imprint LP 22

This yellow round pill with imprint LP 22 on it has been identified as: Methotrexate 2.5 mg.

This medicine is known as methotrexate. It is available as a prescription only medicine and is commonly used for Acute Lymphoblastic Leukemia, Acute Lymphocytic Leukemia, Acute Nonlymphocytic Leukemia, Bladder Cancer, Brain Tumor, Breast Cancer, Bullous Pemphigoid, Cervical Cancer, Choriocarcinoma, Cogan's Syndrome, Colorectal Cancer, Dermatomyositis, Ectopic Pregnancy, Eczema, Esophageal Carcinoma, Gastric Cancer, Graft Versus Host Disease, Head and Neck Cancer, Hodgkin's Lymphoma, Juvenile Idiopathic Arthritis, Lymphoma, Mantle Cell Lymphoma, Meningeal Leukemia, Mycosis Fungoides, Neoplastic Diseases, Non-Hodgkin's Lymphoma, Non Small Cell Lung Cancer, Osteosarcoma, Ovarian Cancer, Pancreatic Cancer, Pemphigoid, Pemphigus, Pityriasis rubra pilaris, Psoriasis, Psoriatic Arthritis, Rheumatoid Arthritis, Scleroderma, Small Cell Lung Cancer, Soft Tissue Sarcoma, Solid Tumors, Systemic Sclerosis, Trophoblastic Disease, Uveitis, Polyarticular Juvenile Idiopathic Arthritis.

Details for pill imprint LP 22

Drug
Methotrexate
Imprint
LP 22
Strength
2.5 mg
Color
Yellow
Shape
Round
Size
6mm
Availability
Prescription only

Pill Classification

National Drug Code (NDC)
477810482 - Alvogen, Inc.